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HIV infections are initiated by a limited number of variants that diverge into a diverse quasispecies swarm.
During in utero mother-to-child transmission (IU MTCT), transmitted viral variants must pass through
multiple unique environments, and our previously published data suggest a nonstochastic model of transmis-
sion. As an alternative to a stochastic model of viral transmission, we hypothesize that viral selection in the
placental environment influences the character of the viral quasispecies when HIV-1 is transmitted in utero. To
test this hypothesis, we used single-template amplification to isolate HIV-1 envelope gene (env) sequences from
both peripheral plasma and the placentas of eight nontransmitting (NT) and nine IU-transmitting partici-
pants. Statistically significant compartmentalization between peripheral and placental HIV-1 env was detected
in one of the eight NT cases and six of the nine IU MTCT cases. In addition, viral sequences isolated from IU
MTCT placental tissue showed variation in env V1 loop lengths compared to matched maternal sequences,
while NT placental env sequences did not. Finally, comparison of env sequences from NT and IU MTCT
participants indicated statistically significant differences in Kyte-Doolittle hydropathy in the signal peptide,
C2, V3, and C3 regions. Our working hypothesis is that the hydropathy differences in Env associated with IU
MTCT alter viral cellular tropism or affinity, allowing HIV-1 to efficiently infect placentally localized cells.
According to UNAIDS estimates, in 2007 there were ap-
proximately 1.4 million HIV-infected pregnant women in
low- and middle-income countries in need of antiretroviral
therapy to prevent HIV-1 mother-to-child transmission
(MTCT). In populations where replacement feeding is not
feasible, it has been estimated that 12% of MTCT occurs in
utero (IU) before 36 weeks gestation, 29% occurs in utero
between 36 weeks and delivery, 20% occurs during labor and
delivery (peripartum), and the remaining 39% occurs during
prolonged breastfeeding (postpartum) (39). Although low-
and middle-income countries have made progress to in-
crease the use of antiretrovirals to prevent peripartum and
postpartum HIV-1 MTCT, in 2007, only 23% of the esti-
mated 73,000 HIV-infected pregnant Malawians had access
to the required antiretrovirals (WHO/UNAIDS/UNICEF
2008 progress report). In addition, access to other preven-
tive measures, such as elective cesarean sections and re-
placement formula feeding, remain unrealized. As the
coverage of new intervention strategies to prevent breast-
feeding and intrapartum transmissions increases, the overall
rate of transmission will decrease, but a greater proportion
of the transmissions will occur in utero via largely unchar-
acterized biological mechanisms (21).
HIV infections are initiated by a single variant or a limited
number of variants that diverge and diversify into a complex
quasispecies swarm (1, 62, 67, 70, 79, 82, 84). In other words,
although a chronically infected pregnant woman has a heter-
ogeneous viral population, the complexity of the viral popula-
tion is severely restricted during transmission, and a homoge-
neous virus population is often seen in vertically infected
infants. Three mechanisms have been proposed to explain this
restriction: (i) transmission of the most abundant viral variant
(stochastic model), (ii) transmission of multiple variants fol-
lowed by selective amplification of host-adapted variants (se-
lective-amplification model), and (iii) limited variant transmis-
sion restricted by host and/or viral biology (selection model)
(85). We have previously reported a transmission bottleneck of
HIV-1 subtype C during in utero MTCT based on a heterodu-
plex tracking assay of the V1/V2 region of env (42), and these
data suggested that the bottleneck was inconsistent with a
stochastic model of transmission. Building on these findings,
we investigated the possibility that selection of viral lineages
underlies transmission of HIV-1 variants in IU MTCT (model
3 above).
There are several opportunities for selective pressure during
IU MTCT. The transmitted variants must cross several cell
layers in the placenta (17) and sequentially adapt to three
unique immune environments: an immunologically developed
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or depleted host, an immunologically blunted placenta, and
finally, an immunologically naïve infant. We hypothesize that
the placental environment provides the selective force for the
phenotype of the viral quasispecies when HIV-1 is transmitted
in utero. To address this hypothesis, we used single-template
amplification to characterize the molecular evolution of HIV-1
maternal quasispecies swarms and the individual lineages that
transmit and those that do not transmit during in utero MTCT.
We report quantitative and qualitative differences in the gp120
region of HIV-1 env in viral populations isolated from periph-
eral and placental compartments. Furthermore, we report se-
quence differences in the env signal peptide, C2, V3, and C3
regions that are associated with MTCT status.
(This research was presented in part at the 16th Conference
on Retroviruses and Opportunistic Infections, the 17th Annual
Meeting on HIV Dynamics and Evolution, and the 2010 Ohio
Collaborative Conference on Bioinformatics.)
MATERIALS AND METHODS
Study participants and clinical isolates. Clinical isolates of virus were ob-
tained from HIV-infected pregnant female participants in the Malaria, HIV, and
Pregnancy (MHP) Cohort from 2001 to 2004 (52, 53) in Blantyre, Malawi.
Institutional review board (IRB) approval was obtained from Ohio State Uni-
versity, the University of North Carolina at Chapel Hill, and the Malawi College
of Medicine Research Ethics Committee; all participants gave written informed
consent. HIV-infected mothers and their infants received nevirapine according
to the HIVNET 012 protocol, which was the standard of care at the time of this
study (27). In the parent MHP study, participants who were seroreactive on two
independent HIV tests were deemed HIV positive. Infant HIV-1 status was
determined by real-time PCR according to the methods of Luo et al. (47) and
classified as nontransmitting (NT) or intrauterine transmission according to the
definitions outlined by Bryson et al. (10). HIV-1-exposed but uninfected infants,
here called NT, were HIV-1 DNA negative both at birth and at 6 weeks post-
partum, while intrauterine-transmission cases were HIV-1 DNA positive within
48 h of birth. Peripheral blood was collected from the pregnant women by
venipuncture, and plasma was isolated according to standard protocols. After
delivery, an incision was made in the middle of the maternal surface of the
placenta, 2 cm long and through half the thickness of the placental tissue, and the
placental blood that pooled in the incision was collected, with the presumption
that the resulting blood likely represented an admixture of maternal and fetal
blood (56). In addition to placental blood, a full-thickness biopsy specimen was
taken from the pericentric area of the placenta and snap-frozen in liquid nitro-
gen. For simplicity, HIV-1 env genes from placental blood and placental biopsy
specimens were aggregated into a single category termed “placenta.” Blood from
the umbilical cord vein was collected, and plasma was prepared; previously, we
demonstrated that HIV-1 variants in umbilical cord blood represented the infant
and not the maternal quasispecies (42). Infant blood was collected from heel
pricks at birth and at 6 and 12 weeks. Constrained by the availability of matched
placental tissue and maternal plasma, we identified 84 NT participants (29 of
which were randomly selected) and 15 IU MTCT cases. Only 9 of the 29 NT
cases and 9 of the 15 intrauterine-transmission cases supported gp160 nested-
PCR amplification from all tissues, which is described below.
Using the quality control tool from the Los Alamos National Laboratory
(LANL) (http://www.hiv.lanl.gov), we determined that all env amplicons were
HIV-1 subtype C, that there was no contamination with common laboratory
isolates, and that there was epidemiological linkage between all mother-placenta-
infant pairs, with one exception. Sequences isolated from MHP sample 2466 were
not monophyletic on the phylogenetic tree; all maternal samples formed on a
single subclade, whereas the matched placental sequences formed another
clade that was not a sister group to the maternal clade. There was no comingling
of the 2,466 sequences with other sequences, so we excluded sample cross-
contamination as the source of this result. This sample was eliminated from
further analysis, resulting in a total of eight NT samples. Three env sequences
from three different mother-placenta pairs were predicted to be intersubtype
recombinants by the LANL quality control tool. In each case, comparison of
these predicted recombinant sequences with their nearest neighbors showed
sequence differences that could be explained by a single large deletion, and
therefore, these sequences are unlikely to be true intersubtype recombinants.
Viral-RNA quantification, extraction, and cDNA synthesis. The HIV-1 RNA
concentrations in peripheral and placental plasma isolates were determined with
the Roche Amplicor HIV-1 Monitor test (version 1.5) (53), which had a lower
threshold of detection of 400 copies/ml; any samples with viral loads below the
lower limit of detection were assigned a value of 200 copies/ml. Differences in
matched viral loads (i.e., peripheral versus placental viral load) were tested with
the Wilcoxon signed-rank test, and differences between unmatched viral loads
(i.e., placental plasma of NT versus placental plasma of intrauterine transmit-
ters) were tested with the two-sample Wilcoxon rank sum (Mann-Whitney) test;
both tests were implemented with STATA version 10.1 (STATA Corp., College
Station, TX). RNA was extracted from 140 l centrifuged plasma using the
QIAamp viral-RNA minikit that was used for other plasma samples. If the
plasma viral concentration was 10,000 RNA copies/ml, samples were concen-
trated by ultracentrifugation at 24,500  g for 1.5 h at 4°C. To extract RNA from
placental biopsy specimens, approximately 100 mg tissue was preincubated for 3
to 4 min in Qiazol lysis reagent, placed in a QIA shredder column, and centri-
fuged for 2 min at 21,130  g. The eluent was processed with the RNeasy Lipid
Tissue minikit (Qiagen), and the RNA was eluted into 50 l of RNase-free
water. RNA was reverse transcribed into cDNA with SuperScript III (Invitrogen
Life Technologies, Carlsbad, CA) as follows: reaction mixtures containing 50 l
RNA, 0.5 mM deoxynucleoside triphosphates (dNTPs), and 0.25 M HIV-1
subtype C-specific primer (OFM19) were heated for 5 min at 65°C and then
quenched on ice. cDNA synthesis was performed in 100 l with 1 reverse
transcriptase buffer, 5 mM dithiothreitol, 80 units RNaseOut, and 1,000 units
SuperScript III (Invitrogen Life Technologies, Carlsbad, CA). The reaction
mixture was sequentially incubated at 50°C and 55°C for 1 h each, inactivated at
70°C for 15 min, incubated with 2 units RNase H (Invitrogen Life Technologies,
Carlsbad, CA), and then digested at 37°C for 20 min. To ensure that only HIV-1
RNA was isolated from placental biopsy specimens, placental tissue extracts
underwent mock cDNA synthesis without SuperScript III; this reaction never
supported PCR amplification, indicating that HIV-1 RNA and not HIV-1 DNA
in the placental biopsy specimen served as the PCR template (data not shown).
Single-template amplification. It has been demonstrated that PCR amplifica-
tion of a related yet heterogeneous mixture of templates is prone to PCR-
induced template recombination, which can be mitigated by performing PCR on
single templates (59, 77). Single-template amplification was performed according
to published protocols (35, 57, 65, 73). Briefly, serial dilutions of cDNA were
made until less than 30% of 8 to 10 replicate PCRs generated amplicons. All
PCRs used High Fidelity Platinum Taq (Invitrogen) according to the manufac-
turer’s instructions and the subtype C-optimized outer primers VIF and OFM19
and inner primers ENVA* and ENVN (the sequences are listed in Table S1 in
the supplemental material).
DNA sequencing. Prior to being sequenced, PCR amplicons were incubated
with exonuclease I (New England BioLabs) and alkaline phosphatase (Roche) at
37°C for 30 min, followed by heat inactivation at 95°C for 5 min (6). Full-length
gp160 was sequenced using eight HIV-1 subtype C-optimized primers (Genewiz,
Inc., NJ) (see Table S1 in the supplemental material), which provided a mini-
mum of 2-fold coverage. The sequencing chromatograms were manually exam-
ined for multiple peaks, and those with multiple concurrent peaks were dis-
carded. env sequences were trimmed, assembled, and manually edited using
Geneious software. All sequences were examined with the HIV Sequence Qual-
ity Control Tool on the Los Alamos National Laboratory HIV database website
(http://www.hiv.lanl.gov). The results from this tool allowed us to exclude poten-
tial contamination with laboratory isolates and to conclude that all env sequences
are most closely related to HIV-1 subtype C (data not shown). The features of
gp41 will be described elsewhere.
Sequence alignment and phylogenetic-tree construction. Cleaned gp160 se-
quences were first aligned, using HMMER (19), to the Env protein model
provided by the LANL. This alignment was manually adjusted in less than 10
instances to correct the alignment of sequence landmarks and to maintain the
reading frame. The adjusted alignment was used to train a new subtype C-specific
Env protein model, followed by alignment of the sequences to this new model
using HMMER. Finally, the alignment was used for a tree search in RAxML (75)
with a general time-reversible substitution model with gamma-distributed rate
heterogeneity and a proportion of invariant sites (GTR-gamma-I; determined
using Findmodel [http://www.hiv.lanl.gov]). The best-scoring tree under the max-
imum-likelihood criterion after 100 replicates is shown in Fig. S1 in the supple-
mental material.
Assessment of recombination. Genetic algorithm recombination detection
(GARD) (38), a standard recombination detection method included in hypoth-
esis testing using phylogenies (HYPHY) (58), was used to screen all epidemio-
logically linked maternal and placental sequences for evidence of recombination.
Significant breakpoints are reported at a P value of 0.05, as reported by
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HYPHY. The phylogenetic tree associated with each segment identified by
GARD was used for the positive-selection analyses described below.
Compartmentalization testing. Using the tree produced by RAxML, Slatkin-
Maddison (74) P values were calculated using the standard analysis packaged in
HYPHY (58). A second test of compartmentalization, the Hudson nearest-
neighbor method (31) was also used; this method is a robust measure of com-
partmentalization when there are unequal numbers of sequences in the two
compartments (83), as is the case for some of the pregnancies in these data. The
analysis was performed both with and without duplicate sequences.
Sequence characteristics. Evidence of APOBEC-induced sequence hypermu-
tation was measured with Hypermut (http://www.hiv.lanl.gov). Hypervariable
loops from the gp120 sequences were extracted with the Gene Cutter program
(http://www.hiv.lanl.gov). Potential N-linked glycosylation sites (PNLGs) on both
gp120 and the individual hypervariable loops were enumerated with the N-gly-
coside program (http://www.hiv.lanl.gov). Coreceptor usage of the subtype C
gp120 genes was predicted from the extracted V3 sequences with the Web
position-specific scoring matrix tool trained for HIV-1 subtype C (PSSM-C),
which is maintained by the University of Washington (32).
Alignment position quality controls and multiple-hypothesis correction. Be-
cause multiple amino acid positions are considered simultaneously, it is nec-
essary to perform a multiple-hypothesis correction. An amino acid position
was included in the analysis if it was a consensus deletion in no more than 2
(of 17) participants and no more than 12 of the participants shared the same
plurality amino acid, excluding those participants for whom the Shannon
entropy at that amino acid position (among different variants) was greater
than 0.4. This minimum diversity requirement excludes amino acid positions
that are too conserved to ever rise above the multiple-hypothesis correction
(see below) based on estimates from Fisher’s exact test (P  0.001, with fewer
than five mothers showing the rare variant amino acid; a Shannon entropy of
0.4 roughly corresponds to a rare-variant frequency of 22%, which should be
detected in 95% of bootstrap replicates.) After filtering, 118 amino acid
positions and their corresponding codons were included in the analyses de-
scribed below. To correct for multiple-hypothesis testing, the Benjamini-
Hochberg method was used with a primary false-discovery rate of less than
0.05; in order to reduce the probability of false-negative results, we also
report a secondary false-discovery rate of 0.25 (7).
Positive and purifying selection. Positions under positive selection were iden-
tified by differences in relative synonymous and nonsynonymous substitution
rates (dN  dS) as reported by the standard analysis packaged with HYPHY
(58), including an adjustment for any recombination detected by GARD. HIV-1
sequences derived from each volunteer were treated separately, and the observed
and expected values for synonymous and nonsynonymous substitution rates were
combined across volunteers after stratification by their transmission status. The
P value for the sum of these substitution rates was obtained using the same
binomial-approximation calculation employed by HYPHY (58). This analysis
was performed only for the 118 codons corresponding to amino acids used in
other analyses, and the same multiple-hypothesis correction was applied.
Bootstrapping method to identify sequence differences associated with in utero
MTCT. For purposes of identifying sequence differences associated with IU
MTCT, comparisons were made at individual sites in HIV-1 env sequences
derived from IU MTCT pregnancies versus those derived from NT pregnancies.
Statistically significant differences were identified using a nested-bootstrapping
procedure (16), with a given pregnancy sampled on the outer layer and individual
sequences from each pregnancy sampled on the inner layer, for a total of 12
sequences per pregnancy per sample (the fewest for any pregnancy). Allowing
this number to match the full number of available sequences did not render any
of the results nonsignificant. At each alignment position, in each bootstrap
replicate (100,000 replicates), the difference between the average Kyte-Doolittle
hydropathy index (43) of the IU MTCT sequences in the sample and the NT
sequences in the sample is calculated. At each alignment position, a given
bootstrap replicate supports the null hypothesis (similar hydropathy) if the dif-
ference is zero or if the difference has a sign opposite to that of the difference
observed in the data set as a whole. The P value at each alignment position is the
fraction of bootstrap replicates in which the null hypothesis is supported (e.g., the
P value drops, becoming more significant, if the difference seen in the data set is
also seen in a large fraction of the bootstrap replicates). The bootstrap P values
were calculated only for the 118 alignment positions where a significant associ-
ation could be detected given the available data (see “Alignment position quality
controls and multiple-hypothesis correction” above).
Feature mapping on the Env crystal structure. Amino acid positions of inter-
est were mapped onto the JRFL Env crystal structure (Protein Data Bank
identifier [PDB ID] 2B4C) using Jmol, an open-source Java viewer for chemical
structures in three dimensions (3D) (http://www.jmol.org/).
Nucleotide sequence accession numbers. The env sequences from the signal
peptide through gp120 (abbreviated sp-gp120) have been deposited in GenBank
(http://ncbi.nlm.nih.gov) under accession numbers JF722674 to JF723201.
RESULTS
Comparison of peripheral and placental plasma-associ-
ated HIV-1 loads. Previous studies from the MHP cohort have
reported an association between malaria and the HIV-1 load
(53), an association between maternal syphilis seroreactivity
and HIV-1 MTCT (52), an association between maternal-in-
fant blood admixture during intrapartum HIV-1 MTCT (40,
41), and a reduction in HIV-1 quasispecies diversity during
HIV-1 MTCT (42). In order to better understand the relation-
ship between the HIV-1 load in peripheral and placental plas-
mas, we stratified viral-load data from the MHP cohort by
HIV-1 transmission status. Table 1 shows the clinical charac-
teristics of the 266 NT and 44 in utero-transmitting HIV-in-
fected women whose peripheral viral loads were quantified; a
subset of 130 NT and 28 IU MTCT cases had matched pla-
cental viral-load data. As shown in Fig. 1, the median placental
HIV-1 concentration among NT women was significantly lower
than the median HIV-1 concentration in matched peripheral
plasma (P  0.0001), while in contrast, the median placental
HIV-1 concentration in intrauterine-transmitting women
was equivalent to or slightly higher than the median HIV-1
concentration in matched peripheral plasma (P  0.2). In
comparisons between the two groups, the median placental
HIV-1 concentration in intrauterine-transmitting women
was significantly higher than in NT women (5.2 log10 cop-
ies/ml versus 3.5 log10 copies/ml, respectively; P  0.0001).
While IU MTCT cases were significantly more likely to be
coinfected with syphilis (consistent with previous reports
[52]), other clinical features did not differ significantly by
transmission status. These results show two distinct differ-
ences in viral loads that are associated with MTCT status.
First, the placental HIV-1 concentration is higher in cases of
IU MTCT than in cases of NT. Second, the relationship
between peripheral and placental HIV-1 concentrations dif-
fers by MTCT status: the vast majority of NT pregnancies
had placental viral loads that were on average an order of
magnitude lower than matched peripheral concentrations,
while the placental viral loads were similar to matched pe-
ripheral viral loads among the IU MTCT pregnancies.
TABLE 1. Clinical features of HIV-infected women with peripheral
and placental HIV-1 viral-load data, stratified by
HIV-1 mother-to-child transmission status





Median age (IQR) (yr) 24 (21, 28) 24 (20, 26) 0.2b
Median CD4 T-cell count
(IQR)
378 (234, 530) 293 (202, 439) 0.2b
% Syphilis seroreactivity (n) 5 (265) 18 (44) 0.002c
% with placental malaria (n) 8 (256) 1 (41) 0.09c
a IQR, interquartile range.
b Kruskal-Wallis equality-of-populations rank test.
c Fisher’s exact test.
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env sequence characteristics. Previous studies from the same
MHP cohort revealed a restriction of HIV-1 env genetic diver-
sity after IU MTCT in a manner inconsistent with a stochastic
mechanism of variant transmission (42). Building on these
data, we tested an alternative model, natural selection of viral
lineages, to explain the genetic restriction observed during IU
MTCT. In order to test this hypothesis, we used single-tem-
plate amplification to isolate HIV-1 env from peripheral
plasma (maternal), various placental tissues (placental plasma
and placental biopsy specimens), and umbilical cord blood
(infant). Table 2 shows the clinical characteristics of the ma-
ternal donor, the number of gp160 amplicons sequenced from
the peripheral and placental compartments, and the biochem-
ical characteristics of the sequences of these matched samples.
A total of 589 gp160 sequences from maternal plasma, placen-
tal plasma, a placental biopsy specimen, cord plasma, neonatal
plasma, and 12-week infant plasma were obtained. After align-
ment and in silico translation, 61 of the 589 sequences (11%)
had multiple stop codons and were excluded from further
analysis; none of the sequences showed evidence of APOBEC
hypermutation (data not shown). The majority of the se-
quences with stop codons were isolated from infant tissues
(P  0.05; Fischer’s exact test). In total, 528 env sequences,
spanning the signal peptide through env gp120 (sp-gp120),
from nine intrauterine-transmission and eight NT participants
are described.
The CD4 T-cell count and HIV concentration have been
correlated with viral population diversity and IU MTCT; there-
fore, it is plausible that the observed sequence differences
between intrauterine transmission and NT samples (see below)
might reflect differences in progression or immunological sta-
tus between the intrauterine-transmission and NT groups. To
address this concern, we calculated the mean viral sequence
diversity for each pregnancy and measured its correlation with
the viral load or CD4 T-cell counts. Maternal viral population
diversity increased in both intrauterine transmission and NT,
with declining CD4 T-cell counts (P  0.003; Pearson’s R2),
but not with rising viral load (Table 2). No significant relation-
ship was observed between transmission status and viral pop-
ulation diversity in either compartment or between maternal
sequences stratified by transmission status (0.04  0.01 substi-
tutions per nucleotide in the intrauterine-transmission mater-
nal sequences and 0.03  0.03 substitutions per nucleotide in
the NT maternal sequences). Therefore, the sequence differ-
FIG. 1. The peripheral and placental HIV-1 RNA concentrations
vary according to both transmission status and tissue compartment.
Each point represents a viral-load measurement from an individual
participant, with the horizontal lines representing the median values. P
values represent the results of Wilcoxon signed-rank tests of log10
peripheral versus log10 placental viral loads or a two-sample Wilcoxon
rank sum test of log10 placental viral loads of NT versus in utero
transmitters (IU).





























M P M P M P M P M P
1639 NT 160,259 NA 375 7 26 0.004 0.003 21 (21) 21 (17, 21) 369 369 30 30
1669 NT 81,178 NA 485 5 13 0.015 0.014 14 (10, 14) 14 (10, 14) 356 356 27 27
1702 NT NA NA 273 12 7 0.017 0.027 17 (17, 33) 19 (13, 33) 357 354 27 27
2437 NT 13,529 NA 445 10 10 0.019 0.036 19 (19) 19 (17, 19) 361 359 26 26
2502 NT 154,972 NA 38 12 15 0.070 0.061 20 (13, 20) 20 (14, 20) 372 370 28 28
2512 NT 23,301 NA 222 7 6 0.040 0.054 21 (20, 23) 22 (20, 29) 358 361 24 25
2544 NT 587,702 NA NA 19 19 0.018 0.024 17 (17) 17 (17) 360 358 25 25
3274 NT NA NA 103 13 18 0.073 0.063 15 (9, 25) 15 (9, 18) 361 361 26 26
1468 IU 36,453 87,276 274 17 6 0.035 0.040 12 (12, 17) 12 (12, 17) 356 355 26 25
1472 IU 51,551 24,116 397 16 12 0.028 0.048 17 (13, 19) 13 (13, 19) 370 360 28 26
1485 IU 125,813 708,115 329 7 34 0.051 0.014 21 (10, 31) 10 (10, 21) 364 361 28 19
1646 IU 902,778 NA 95 14 9 0.050 0.040 17 (16, 24) 16 (16, 23) 364 364 26 26
1851 IU NA NA 761 6 6 0.015 0.040 8 (8, 11) 9 (8, 9) 355 356 23 27
2080 IU 165,000 NA 91 14 7 0.052 0.037 15 (14, 38) 14 (14) 365 365 26 25
2400 IU 98,793 NA 439 16 43 0.043 0.022 17 (17, 22) 22 (17, 22) 349 353 24 26
2797 IU NA NA 399 14 18 0.041 0.002 23 (17, 27) 23 (23) 345 344 26 25
3321 IU NA NA 220 8 11 0.065 0.047 24 (11, 38) 35 (16, 35) 357 357 26 27
a M, maternal plasma; P, placental tissue; VL, viral load; V, variable; C, conserved; NA, no data available.
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ences observed in the sequencing subcohort are unlikely to be
a proxy for disease progression or immunological status.
Regardless of transmission status, there was variability in the
env length within the nine intrauterine-transmission and eight
NT isolates (Table 2). First, we compared the median lengths
of the hypervariable regions of gp120 (V1 to V5) isolated from
matched placental and maternal plasmas. Within single partic-
ipants, insertions and deletions occurred most frequently in env
V1. The median env V1-V5 lengths between epidemiologically
linked sp-gp120 sequences were similar in six of eight NT
isolates, but in seven of the nine IU MTCT isolates, the env
V1-V5 loop lengths were different (either longer or shorter).
These differences were most robust in the env V1 loop, where
differences as great as 12 amino acids between epidemiologi-
cally linked samples were observed (Table 2). On average, env
V1 loops from matched IU MTCT maternal-peripheral and
placental samples differ in length by 4 amino acids in spite of
the epidemiological linkage. This is equal to the average dif-
ference between env V1 loop lengths from different mothers
(not epidemiologically linked) and much greater than the av-
erage of 1 amino acid change in average env V1 loop lengths
seen between NT maternal-peripheral and placental se-
quences. Finally, this is in strong contrast to other regions of
gp120; for example, the entire region from the end of env V1
to the end of env C5 (V2-C5 length in Table 2), which is over
20 times as long as env V1 on average, shows an average length
change of 8 amino acids between different mothers but an
average change of only 3 amino acids in length when matched
IU MTCT maternal-peripheral sequences were compared to
placental sequences. The absolute change in average env V1
loop lengths is significantly greater in IU MTCT pregnancies
than in NT pregnancies (P  0.02; Wilcoxon’s rank sum test),
but the absolute change in average env C2-V5 length did not
differ significantly by transmission status (P  0.5; Wilcoxon’s
rank sum test). The contrast between env V1 length differences
(high between tissues from the same participant and low be-
tween mothers) and env C2-V5 length differences (low be-
tween tissues from the same participant and high between
mothers) indicates that the env V1 length differences observed
are not simply an indirect consequence of overall sequence
differences associated with a placental compartment. This sug-
gests that over a short evolutionary time frame, the env V1
loop among IU MTCT isolates varies tremendously between
the periphery and the placenta.
Consistent with the env V1 loop length data, differences in
the numbers of PNLGs in epidemiologically linked plasma/
placental isolates were observed in eight of nine IU MTCT
samples, while NT pairs had similar numbers of PNLGs in
seven of eight samples (Table 2). The average number of
PNLGS differed between the maternal-peripheral and placen-
tal compartments in each transmitting participant, but not in
nontransmitting participants (P  0.008 by the Wilcoxon rank
test). However, the change in PNLGs was closely correlated
with the change in overall loop length (Pearson R, 0.81; sig-
nificant to a P value of 0.005). In one extreme case, the
placental variants from one IU MTCT pair (MHP1485) had
nine additional PNLGs.
Overall, env V3 loop lengths were consistent between pla-
cental and peripheral variants, and evidence of predicted
CXCR4 (X4) tropism was identified in 100 of the 528 se-
quences (19%) and 10 of the 17 (59%) epidemiologically
linked isolates: four of eight NT and six of nine intrauterine
transmission mother-placenta pairs. In all cases, if predicted
X4 tropism was found in the peripheral blood, it was also
found in the placental tissue. Infant samples were available for
five cases of IU MTCT, and two infants had env sequences with
a predicted X4-tropic phenotype.
Next, we used GARD to identify significant recombination
breakpoints in the sp-gp120 sequences. The eight NT mothers
had 3.0  2.0 recombination breakpoints significant at a P
value of 0.05, while the nine intrauterine-transmtting moth-
ers had 3.4  1.7 recombination breakpoints at the same sig-
nificance threshold. It is possible that recombination might
interfere with the detection of a real compartment (discussed
below). In this case, however, the intrauterine-transmitting
mothers (in whom significantly more HIV-1 compartmental-
ization is detected) also show more recombination in sp-gp120,
although the difference is not significant.
The phylogenetic trees produced by GARD were used to
calculate dN  dS values and the dN and dS values were
pooled among volunteers according to transmission status to
identify amino acid positions/codons that are under statistically
significant positive (dN  dS 	 0) or purifying (dN  dS  0)
selection. Positions 279 and 230 in the intrauterine transmitters
were under significant purifying selection, with dN  dS values
of 1.41 and 1.17 (HXB2 coordinates; false-discovery rates,
0.05 and 0.25, respectively). In the NT group, positions 62
and 92 were also under purifying selection, with dN  dS
values of 0.72 and 1.28 (HXB2 coordinates; false-discovery
rate, 0.25). Figure 2 shows that the intrauterine-transmission
positions under purifying selection are clustered in env C2 and
that the NT positions under purifying selection are in env C1.
env sequence differences associated with transmission status.
We identified several characteristic sequence differences asso-
ciated with MTCT, which are shared by the viral variants
present in the IU MTCT participants regardless of their tissue
of origin. In order to better understand these differences and
determine the statistical significance of the observed differ-
ences, we converted the observed amino acids to a quantitative
measurement and used a nested-bootstrapping method to
measure differences in Kyte-Doolittle hydropathy at individual
gp-120 amino acid positions, stratified by mother-to-child
transmission status. Hydropathy was chosen over other mea-
sures of amino acid physical properties because it is especially
sensitive to amino acid changes that alter the energetics of
ligand-binding interactions, which are dominated by interac-
tions between the protein and the solvent (23). Among the 120
amino acid positions with significant amino acid variability,
statistically significant differences in hydropathy as a function
of transmission status were identified at gp-120 amino acid
positions 6 and 365 (HXB2 coordinates; false-discovery rate,
0.05) and amino acid positions 291, 305, and 335 (false-discov-
ery rate, 0.25) (Fig. 3). The most frequent amino acids at the
individual positions, segregated by transmission status, are dis-
played in Table 3 using sequence logos (13, 68). For compar-
ison, the most frequent amino acids among HIV-1 subtype C
env genes currently deposited in the Los Alamos HIV-1 data-
base are shown in the final column (only one sequence per
patient was included in the analysis). Note that although amino
acids at low frequency can produce a statistically significant
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result, the nested-bootstrapping method requires those rare
amino acids to be present in all or most participants in order to
produce a significant P value. Using the same false-discovery
thresholds, no significant differences in hydropathy were found
between sequences in the same transmission type but from
different tissues; this is in notable contrast to the V1 loop
length differences described above.
Placental compartmentalization. The quantitative data pre-
sented in Fig. 1 indicate that the viral load in the placenta is not
equivalent to that in the periphery. This result could indicate
FIG. 2. Several positions in Env show statistically significant selection. The vertical axis shows the P value for each codon among all HIV-1
sp-gp120 sequences stratified by transmission status; all significant positions are under purifying selection. The P values correspond to the
probability of at most the observed number of nonsynonymous substitutions given the synonymous substitutions and amino acids observed (as
estimated using HYPHY). These results account for any recombination breakpoints identified by GARD. The horizontal axis shows amino acid
positions within sp-gp120, which are numbered according to the HXB2 reference sequence. The dashed lines indicate the thresholds for statistical
significance at false-discovery rates (FDR) of 0.05 and 0.25. The shaded areas indicate the hypervariable (V) or conserved (C) domain of env, also
according to the HXB2 reference sequence.
FIG. 3. Several positions in Env are associated with in utero mother-to-child transmission. Shown are amino acid positions where differences
in Kyte-Doolittle hydropathy values at the individual positions of HIV-1 sp-gp120 are associated with transmission status. The P values (vertical
axis) shown correspond to the fraction of bootstrap replicates in which the sign of the observed hydropathy difference is maintained. The dashed
lines indicate the thresholds for statistical significance at false-discovery rates of 0.05 and 0.25. The shaded areas indicate the hypervariable (V) or
conserved (C) domains of env, also according to the HXB2 reference sequence (horizontal axis).
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an independent compartment of HIV-1 replication. In order to
test the hypothesis that HIV-1 is compartmentalized in the
placenta during IU MTCT, both a tree-based (Slatkin-Maddi-
son [74]) and a distance-based (Hudson fixation index [FST]
[31]) test of compartmentalization were performed on the sp-
gp120 sequences isolated from the placenta and peripheral
plasma (phylogenetic trees and highlighter plots are shown in
Fig. S2 in the supplemental material). In seven of the eight NT
pregnancies, both tests failed to support statistically significant
compartmentalization (defined as a P value of 0.05) between
the placenta and the maternal periphery (Table 4). In contrast,
six of the nine intrauterine-transmission pregnancies showed
significant compartmentalization (P  0.05) by either the tree-
based Slatkin-Maddison test or the Hudson FST nearest-neigh-
bor test. The discordant results between these tests of com-
partmentalization could be a result of the different numbers of
sequences sampled in the two potential compartments, in
which case the Hudson FST is reportedly a more sensitive test
of compartmentalization (83). Exclusion of duplicate se-
quences attenuated the significance of the compartmentaliza-
tion tests, but it did not alter the general association between
compartmentalization and IU MTCT. In addition, five of the
nine groups of intrauterine-transmission isolates (MHP ID
1468, 1485, 1851, 2400, and 2797) and one of the NT isolates
(MHP ID 2437) showed evidence of local viral replication in
the placenta (see Fig. S2 in the supplemental material). Over-
all, the intrauterine-transmission pregnancies showed more
compartmentalization, as assessed by a Wilcoxon sum-of-ranks
test on the P values associated with each individual volunteer:
P  0.0006 for Slatkin-Maddison with duplicates; P  0.02 for
Slatkin-Maddison without duplicates; P  0.02 for Hudson
nearest neighbor with duplicates; and P  0.12 for Hudson
nearest neighbor without duplicates.
DISCUSSION
This study was designed to test the hypothesis that selected
HIV-1 variants cross the placental barrier and cause IU
TABLE 3. Changes in hydropathy at several Env positions are correlated with in utero mother-to-child transmissiona





Most frequent amino acid(s), as sequence logoc
Most frequent amino acids
in the Los Alamos HIV-






6 SP 3.2 0.0001
291 C2 0.6 0.004
305 V3 0.2 0.005
335 C3 1.8 0.008
365 C3 0.7 0.0001
a Shown are the individual amino acid (aa) positions, according to HXB2 numbering, and the corresponding subdomain of Env where that position is found (SP,
signal peptide; V, variable; C, conserved).
b Difference in mean hydropathy indicates the difference in the bootstrap mean estimate of the Kyte-Doolittle hydropathy at the position, stratified by transmission
status. A positive value indicates more hydrophobic residues in in utero mother-to-child transmission (IU); a negative value indicates more hydrophobic residues in the
nontransmitters (NT).
c The most frequent amino acids are displayed using sequence logo, where the size of the letter is proportional to its frequency. The P values represent the raw (not
multiple-hypothesis-corrected) correlation between hydropathy at the position and the transmission status.
d The most frequent amino acids in 757 HIV-1 subtype C sequences in the Los Alamos HIV database.
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MTCT. After genotypically characterizing 528 env genes from
matched peripheral and placental tissues of pregnant women
with documented HIV-1 vertical-transmission status, we ob-
served the following: (i) tissue-specific differences in viral
loads, which varied by HIV-1 transmission status; (ii) discor-
dant env V1 lengths between peripheral and placental HIV-1
isolated from cases of IU MTCT; (iii) phylogenetic reconstruc-
tion consistent with the presence of a placental compartment;
and (iv) differences in env hydropathy within the env-CD4
binding interface that are associated with IU MTCT.
There are several limitations to these findings, including the
following: a small sample size at the participant level, which
limits the generalizability of our findings, and a potential bias
toward the characterization of the most abundant viral vari-
ants, which is an inherent limitation of single-template ampli-
fication. In addition, HIV-1 isolated from the placenta can be
a proxy for infant HIV present in the fetal vasculature within
the placenta (56). Maternal-fetal blood admixture could con-
found the interpretation of the placenta-specific observations,
but the following observations argue against the placenta rep-
resenting only infant blood. First, viral diversity in the placen-
tal biopsy specimens did not differ by transmission status (P 
0.8; Student’s t test). Second, infant sequences are generally
homogeneous and therefore unlikely to contribute significantly
to viral diversity (54, 61). Third, compartmentalization tests
comparing infant env sequences to placental env sequences
indicated the presence of both a placental and an infant com-
partment in three of five mother-infant pairs. Nevertheless,
even if these findings were to represent the characteristics of
HIV-1 in the infant and not the placenta, these data are still
important because they suggest features of env that could be
associated with enhanced viral fitness in the immunologically
naïve newborn.
Although we observed genotypic differences between pe-
ripheral and placental HIV-1 isolates (varied env V1 loop
lengths) and codon-specific differences in hydropathy between
isolates from in utero transmitters versus nontransmitters, the
environmental pressures that selected for these changes in env
are unknown. Immunological pressures on viral replication are
a likely selective force, and several of the observed differences
in env in this report have previously been associated with im-
mune escape. For example, extension of the V1 loop length has
been associated with neutralizing-antibody escape through a
hypothesized “glycan shield” masking mechanism (64, 81). Our
data do not show a consistent increase or decrease in env V1
loop length between anatomical compartments; rather, we ob-
served that the env V1 loops are frequently different during IU
MTCT. Amino acid 230, which is under purifying selection in
the intrauterine-transmission cases, is an established glycosy-
lation site, and amino acid 279 is within the N-linked glycosy-
lation site pattern and could potentially influence the efficiency
of glycosylation. In addition, one of the positions with different
hydropathy values is located on the 
2 helix of env C3 (HXB2
position 335), and this position is a known target of autologous
neutralizing antibodies (51) and likely relevant to neutralizing-
antibody escape (25, 63). Although the sensitivity of the env
isolates from this study to antibody neutralization has not been
tested, another study using samples from the MHP cohort
failed to detect altered sensitivity of in utero-transmitted Env
variants to autologous, heterologous, or the well-characterized
monoclonal antibodies (63a). It is currently unknown if alter-
ations in these Env positions allow HIV-1 to escape other
antibody-directed immune reactions, such as antibody-depen-
dent cellular cytotoxicity (ADCC).
In addition to selective pressure from the immune system,
the differences in env associated with either placental localiza-
tion or in utero MTCT could also be a result of viral adaptation
to the tissues of the placenta, which has a unique repertoire of
TABLE 4. Evidence for placental compartmentalization of HIV-1 env sequences
MHP no.a MTCTstatus
Compartmentalization test results (P value)b
Maternal vs. placental Child vs. placental
Maddison-Slatkin Hudson NN Maddison-Slatkin Hudson NN
Dup. No dup. Dup. No dup. Dup. No dup. Dup. No dup.
1639 NT 0.4 0.1 1 0.4 NA NA NA NA
1669 NT 1 1 0.8 0.9 NA NA NA NA
1702 NT 0.2 0.3 0.07 0.09 NA NA NA NA
2437 NT 0.1 0.1 0.03 0.04 NA NA NA NA
2502 NT 0.9 0.9 0.6 0.5 NA NA NA NA
2512 NT 0.5 0.4 0.1 0.1 NA NA NA NA
2544 NT 0.6 0.6 0.2 0.2 NA NA NA NA
3274 NT 0.8 0.8 0.2 0.2 NA NA NA NA
1468 IU 0.009 0.02 0.002 0.002 NA NA NA NA
1472 IU 0.03 0.03 0.1 0.3 1 0.1 0.04 0.05
1485 IU 0.001 0.04 0.001 0.01 1 1 0.5 0.8
1646 IU 0.5 0.5 0.09 0.09 NA NA NA NA
1851 IU 0.3 0.3 0.02 0.04 NA NA NA NA
2080 IU 0.2 0.2 0.4 0.4 NA NA NA NA
2400 IU 0.001 0.02 0.001 0.2 0.02 0.1 0.02 0.3
2797 IU 0.001 0.001 0.001 0.001 0.5 1 0.2 0.5
3321 IU 0.5 0.8 0.2 0.4 0.001 0.001 0.001 0.001
a The MHP number is the participant’s unique number.
b Results of a tree-based (Slatkin-Maddison) and distance-based (Hudson) nearest-neighbor (NN) test of compartmentalization. Statistically significant compart-
mentalization (P  0.05) is shaded. Dup. and No dup. indicate whether duplicate sequences were included in the analysis. NA, not available.
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cellular targets for viral infection. The maternal-fetal placental
barrier is comprised of several cell layers, including syncy-
tiotrophoblast and cytotrophoblasts, and in the absence of
placental lesions, it is presumed that HIV-1 crosses through
these cells during in utero MTCT. To date, there are no pub-
lished data that support maternal-fetal blood admixture as a
mechanism of in utero HIV-1 mother-to-child transmission (40,
41, 46). Thus, our working assumption is that HIV-1 must cross
an intact maternal-fetal barrier during in utero MTCT. Several
studies have demonstrated HIV-1 infection of trophoblasts
and syncytiotrophoblast in both immortalized and primary tro-
phoblasts (4, 5, 15, 50, 71). Paradoxically, it has also been
reported that syncytiotrophoblast express either a low level of
CD4 or CCR5 molecules or none (18, 44), although this find-
ing is inconsistent (14, 50). Trophoblasts are known to express
various C-type lectins, like gelatins, DC SIGN, globoside, and
syndecans, on their surfaces (12, 33, 34), many of which can
serve as attachment receptors for HIV-1 in CD4-negative cell
lines (8, 20, 28, 45, 80). Because env V1 length and glycosyla-
tion are important in several aspects of the viral life cycle,
including replication competence (76), tropism (9, 26), and
cytopathology (37, 55, 76), it is possible that the observed
differences in env V1 loop lengths between peripheral and
placental compartments in cases of in utero transmission are a
manifestation of placental adaptation, such as an increased
adherence to C-type lectins.
After comparing sequences from participants stratified by
transmission status, we found significant differences in hydrop-
athy between intrauterine-transmission and NT isolates at sev-
eral amino acid positions. Hydrophobicity was chosen for this
application in order to be maximally sensitive to mutations
between polar and nonpolar residues. However, the mutations
identified (Table 3) include two relatively conservative K-to-R
mutations. Although less conservative mutations are expected
to have a stronger impact on the biochemistry of the protein
product, this is not always the case—even relatively conserva-
tive amino acid substitutions may have significant biological
effects (36). Although they were not associated with placental
localization, it is possible that the sp-gp120 env positions asso-
ciated with in utero MTCT are also a marker of placental
adaptation. One of the five hydrophobicity changes (position
365) and one of the positions under purifying selection during
intrauterine transmission (position 279) are likely in direct
contact with the CD4 molecule (Fig. 4). In addition to its role
in binding the CD4 molecule, it has been shown that the amino
acid sequence of env V3 through C3 is similar to those of the
chemokines that bind either CCR5 or CXCR4 (72). Perhaps
the observed changes in env associated with in utero mother-
to-child transmission expand the repertoire of coreceptors
available to HIV-1 for entry into cells in the placenta or infant.
Finally, the observation that during in utero MTCT the pla-
centa shows phylogenetic evidence of viral compartmentaliza-
tion is consistent with the hypothesis that HIV-1 has adapted to
the placental environment. HIV-1 compartmentalization has
been described in semen (2, 11) and brain (69), kidney (49), and
metastatic (66) tissue, but limited, if any, HIV-1 compartmental-
ization has been observed in breast milk (29, 30). Sites of HIV-1
infection in the placenta that could produce a distinct compart-
ment include placental macrophages, trophoblasts, decidual
mononuclear cells, and T-cell infiltrates in the intervillous space
and decidua (3, 4, 48). Placental macrophages (PMs) express
lower levels of the CD4, CXCR4, and CCR5 receptors than
monocyte-derived macrophages (MDMs) in the peripheral blood
compartment (22, 78). Though CD4 and coreceptor expression is
low, viral integration does not differ between PMs and MDMs,
(24), suggesting that alternate coreceptors or enhanced affinity
may be involved in infection of placental macrophages.
In summary, this study supports viral compartmentalization
in the placenta during IU MTCT, and it identified changes in
the CD4-gp120 binding interface that correlate with IU
MTCT. Our working hypothesis is that these mutations alter
viral tropism, allowing HIV-1 to efficiently infect cells in the
placenta. Whether this model is relevant for all HIV-1 sub-
types or just subtype C, which has been shown to be transmit-
ted in utero more frequently than HIV-1 subtypes A and D
(60), remains to be evaluated. Future studies addressing the
phenotypic consequences of these findings could provide in-
sight into the mechanism of in utero HIV-1 mother-to-child
transmission.
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4. Backé, E., et al. 1992. Demonstration of HIV-1 infected cells in human
placenta by in situ hybridisation and immunostaining. J. Clin. Pathol. 45:
871–874.
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